Guidelines for breast cancer treatment in Bosnia and Herzegovina

• Published in: Bosnian journal of basic medical sciences 2022-07
• Main Authors: Hadžikadić-Gušić, Lejla, Cerić, Timur, Marijanović, Inga, Iljazović, Ermina, Koprić, Dijana, Zorlak, Anela, Tanović, Mahira, Mekić-Abazović, Alma, Šišić, Ibrahim, Delić, Una, Mustedanagić-Mujanović, Jasminka, Aginčić, Alija, Bećiragić, Edin, Greene, Frederick
• Format: Article
• Language: English
• ISSN: 1512-8601; 1840-4812
• DOI: 10.17305/bjbms.2022.7504

Breast cancer is the most common cancer among women. In Bosnia and Herzegovina, accurate data on the status of breast cancer are lacking due to the absence of a central registry. Multiple international guidelines imply that institutions that monitor breast cancer patients should have optimal therapeutic options for treatment. In addition, there have been several international consensus guidelines written on the management of breast cancer. Application of consensus guidelines have previously been demonstrated to have a positive influence on breast cancer care. The importance of specialty breast centers has previously been reported. As part of the 2021 Bosnian-Hercegovinian American Academy of Arts and Sciences (BHAAAS) conference in Mostar, a round table of multidisciplinary specialists from Bosnia and Herzegovina and the diaspora was held.  All were either members of BHAAAS or regularly participate in collaborative projects.  The focus of the consortium was to write the first multidisciplinary guidelines for the general management of breast cancer in Bosnia and Herzegovina. The grading system used is reported in Table 1. Statements without use of a grading system were considered standard clinical practice by our panel of experts (see Table 2). Guidelines were developed for each area of breast cancer treatment and management. These guidelines will serve as a resource for practitioners managing breast cancer in the Bosnia and Hercegovina region. This might also be of benefit to the ministry of health and any future investors interested in developing breast cancer care policies in this region of the world.